Customizing Therapy for Esophageal Cancer: CROSS vs. FLOT

被引：0
|
作者：
Tasnim, Sadia [1 ]
Sudarshan, Monisha [1 ]
机构：
[1] Cleveland Clin, Dept Thorac Surg, Cleveland, OH 44103 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2024年 / 31卷 / 01期
关键词：
D O I：
10.1245/s10434-023-14320-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：21 / 22
页数：2
相关论文
共 50 条
  • [11] Neoadjuvant Chemoradiation (CROSS) vs. Perioperative Chemotherapy (FLOT) in Esophageal Adenocarcinoma (EAC): ESOPEC - a Randomised Controlled Prospective Multicentre Phase Ill Trial
    Brunner, T. B.
    Lordick, F.
    Schmoor, C.
    Schmidberger, H.
    Kirste, S.
    Rieken, S.
    Petersen, C.
    Nicolay, N. H.
    Fokas, E.
    Dunst, J.
    Rades, D.
    Eble, M. J.
    Krause, M.
    Roedel, C.
    Medenwald, D.
    Niehoff, P.
    Wittig-Sauerwein, A.
    Baues, C.
    Grosu, A.
    Hoeppner, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S6 - S6
  • [12] CROSS Vs FLOT in distal or esophageal gastric junction adenocarcinoma. Mono-institutional experience
    Slim, Najla
    Castellano, Marco
    Mazza, Elena
    Purrello, Giorgio
    Passoni, Paolo
    Elmore, Ugo
    Torrisi, Miriam
    Liscia, Nicole
    Cossu, Andrea
    Albarello, Luca
    Puccetti, Francesco
    Barbieri, Lavinia
    Broggi, Sara
    Midulla, Martina
    Deli, Aniko Maria
    Giannini, Laura
    Fiorino, Claudio
    Cascinu, Stefano
    De Cobelli, Francesco
    Rosati, Riccardo
    Di Muzio, Nadia
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2205 - S2206
  • [13] Volumetric Modulated Are Therapy Vs. C-IMRT for the Treatment of Upper Thoracic Esophageal Cancer
    Zhang, W.
    Wu, L.
    Lu, J.
    Chen, C.
    MEDICAL PHYSICS, 2015, 42 (06) : 3524 - 3524
  • [14] Comparison of oncologic Results with preoperative Radiochemotherapy (CROSS) vs. perioperative Chemotherapy (FLOT) in Patients with Adenocarcinoma of the esophagogastric Junction
    Leu, M.
    Mahler, H.
    Doering, K.
    Possiel, J.
    Guhlich, M.
    Droege, L. H.
    Koenig, A. Otto
    Rieken, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S32 - S32
  • [15] Prevention strategies for esophageal cancer: Perspectives of the East vs. West
    Chung, Chen-Shuan
    Lee, Yi-Chia
    Wu, Ming-Shiang
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2015, 29 (06) : 869 - 883
  • [16] Volumetric Modulated Arc Therapy vs. c-IMRT for the Treatment of Upper Thoracic Esophageal Cancer
    Zhang, Wu-Zhe
    Zhai, Tian-Tian
    Lu, Jia-Yang
    Chen, Jian-Zhou
    Chen, Zhi-Jian
    Li, De-Rui
    Chen, Chuang-Zhen
    PLOS ONE, 2015, 10 (03):
  • [17] Multimodale Therapie des Magenkarzinoms und Karzinoms des gastroösophagealen Übergangs – ECF vs. FLOTMultimodal therapy for gastric or gastroesophageal junction adenocarcinoma —ECF vs. FLOT
    W. Schröder
    C. J. Bruns
    Der Chirurg, 2019, 90 (Suppl 2): : 27 - 27
  • [18] Multimodale Therapie des Magenkarzinoms und Karzinoms des gastroösophagealen Übergangs – ECF vs. FLOTMultimodal therapy for gastric or gastroesophageal junction adenocarcinoma —ECF vs. FLOT
    W. Schröder
    C. J. Bruns
    Der Chirurg, 2017, 88 (6): : 540 - 540
  • [19] Endarterectomy vs. stenting vs. medical therapy
    Spence, J. David
    INTERNATIONAL JOURNAL OF STROKE, 2016, 11 (05) : 500 - 501
  • [20] Personalized Cancer Therapy Design: Robustness vs. Optimality
    Fleck, Julia L.
    Cassandras, Christos G.
    2016 IEEE 55TH CONFERENCE ON DECISION AND CONTROL (CDC), 2016, : 5041 - 5046
12345